Insulet (PODD) Amortization of Deferred Charges (2010 - 2026)
Insulet's (PODD) quarterly Amortization of Deferred Charges came in at $700000.0 in Q1 2026, down 72.0% YoY from $2.5 million in Q1 2025, and down 12.5% on a QoQ basis from $800000.0 in Q4 2025.
Insulet (PODD) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Amortization of Deferred Charges data on file, last reported at $700000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 72.0% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 40.0% YoY) and the FY2025 annual result came in at $6.2 million, down 15.07% from the prior year.
- Amortization of Deferred Charges retreated to $700000.0 in Q1 2026, from $800000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $2.5 million in Q1 2025 to a low of $400000.0 in Q2 2025.
- A 5-year average of $1.3 million and a median of $1.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges slumped 81.93% — and 2025, when it soared 112.5%.
- Tracing PODD's Amortization of Deferred Charges over 5 years: stood at $1.5 million in 2022, then jumped by 40.0% to $2.1 million in 2023, then fell by 9.52% to $1.9 million in 2024, then plunged by 57.89% to $800000.0 in 2025, then retreated by 12.5% to $700000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $700000.0 (Q1 2026), $800000.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Insulet | 10.31 Bn | 9.77 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |